BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16689711)

  • 1. The future of health economic modeling: have we gone too far or not far enough?
    Fendrick AM
    Value Health; 2006; 9(3):179-80. PubMed ID: 16689711
    [No Abstract]   [Full Text] [Related]  

  • 2. Bringing health economic modeling to the 21st century.
    Eddy D
    Value Health; 2006; 9(3):168-78. PubMed ID: 16689710
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation in health care: the point of view of informed physicians.
    Fattore G; Torbica A
    Value Health; 2006; 9(3):157-67. PubMed ID: 16689709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equity and the economic evaluation of healthcare.
    Sassi F; Archard L; Le Grand J
    Health Technol Assess; 2001; 5(3):1-138. PubMed ID: 11207451
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness analysis in heart disease, Part I: General principles.
    Kupersmith J; Holmes-Rovner M; Hogan A; Rovner D; Gardiner J
    Prog Cardiovasc Dis; 1994; 37(3):161-84. PubMed ID: 7972851
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Researcher-driven versus policy-driven economic appraisal of health technologies: the case of France.
    Moatti JP; Chanut C; Benech JM
    Soc Sci Med; 1994 Jun; 38(12):1625-33. PubMed ID: 8047920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Being economical with the truth: how to make your idea appear cost effective.
    Goodacre S; McCabe C
    Emerg Med J; 2002 Jul; 19(4):301-4. PubMed ID: 12101135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISPOR's Initiative on US Value Assessment Frameworks: Seeking a Role for Health Economics.
    Sculpher M
    Value Health; 2018 Feb; 21(2):171-172. PubMed ID: 29477397
    [No Abstract]   [Full Text] [Related]  

  • 11. ISPOR's Initiative on US Value Assessment Frameworks: The Use of Cost-Effectiveness Research in Decision Making among US Insurers.
    Solow B; Pezalla EJ
    Value Health; 2018 Feb; 21(2):166-168. PubMed ID: 29477395
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in economic outcomes research.
    Cook JR
    Hepatology; 1999 Jun; 29(6 Suppl):23S-25S. PubMed ID: 10386079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISPOR's Initiative on US Value Assessment Frameworks: An Industry Perspective.
    Burkholder R; Dougherty JS; Neves LA
    Value Health; 2018 Feb; 21(2):173-175. PubMed ID: 29477398
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic evaluation of health care and policymaking.
    Johannesson M
    Health Policy; 1995 Sep; 33(3):179-90. PubMed ID: 10145120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Philosophical concerns regarding cost-effectiveness analyses.
    Weiner BK
    Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and Patients.
    Perfetto EM
    Value Health; 2018 Feb; 21(2):169-170. PubMed ID: 29477396
    [No Abstract]   [Full Text] [Related]  

  • 17. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 18. The economic evaluation of health care.
    Haas M; Hall J
    Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health policy and outcomes research 2004.
    Matchar DB; Rudd AG
    Stroke; 2005 Feb; 36(2):225-7. PubMed ID: 15637316
    [No Abstract]   [Full Text] [Related]  

  • 20. Modelling programme costs in economic evaluation.
    Fenn P; McGuire A; Backhouse M; Jones D
    J Health Econ; 1996 Feb; 15(1):115-25. PubMed ID: 10157425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.